Temozolomide-induced flare in high-grade gliomas: a new clinical entity.
Publication
, Journal Article
Rosenthal, MA; Ashley, DL; Cher, L
Published in: Intern Med J
July 2002
A transient deterioration in neurological status following commencement of chemotherapy for high-grade gliomas has not been previously described. We report eight cases of transient deterioration following administration of temozolomide, a relatively new cytotoxic agent used in the treatment of high-grade gliomas. We believe this represents the novel clinical entity of temozolomide-induced tumour flare.
Duke Scholars
Published In
Intern Med J
DOI
ISSN
1444-0903
Publication Date
July 2002
Volume
32
Issue
7
Start / End Page
346 / 348
Location
Australia
Related Subject Headings
- Temozolomide
- Severity of Illness Index
- Risk Factors
- Retrospective Studies
- Prognosis
- Middle Aged
- Male
- Karnofsky Performance Status
- Humans
- Glioma
Citation
APA
Chicago
ICMJE
MLA
NLM
Rosenthal, M. A., Ashley, D. L., & Cher, L. (2002). Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J, 32(7), 346–348. https://doi.org/10.1046/j.1445-5994.2002.00242.x
Rosenthal, M. A., D. L. Ashley, and L. Cher. “Temozolomide-induced flare in high-grade gliomas: a new clinical entity.” Intern Med J 32, no. 7 (July 2002): 346–48. https://doi.org/10.1046/j.1445-5994.2002.00242.x.
Rosenthal MA, Ashley DL, Cher L. Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J. 2002 Jul;32(7):346–8.
Rosenthal, M. A., et al. “Temozolomide-induced flare in high-grade gliomas: a new clinical entity.” Intern Med J, vol. 32, no. 7, July 2002, pp. 346–48. Pubmed, doi:10.1046/j.1445-5994.2002.00242.x.
Rosenthal MA, Ashley DL, Cher L. Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J. 2002 Jul;32(7):346–348.
Published In
Intern Med J
DOI
ISSN
1444-0903
Publication Date
July 2002
Volume
32
Issue
7
Start / End Page
346 / 348
Location
Australia
Related Subject Headings
- Temozolomide
- Severity of Illness Index
- Risk Factors
- Retrospective Studies
- Prognosis
- Middle Aged
- Male
- Karnofsky Performance Status
- Humans
- Glioma